Medical News / ENDO Congress 2021: Atypical Thyroid Inflammation Observed in Early COVID-19 Patients

Persistent atypical thyroid gland inflammation may be prevalent in patients with COVID-19, according to new findings from a three-month assessment conducted during the beginning of the pandemic. In data presented by a team of Italian investigators at ENDO 2021 this weekend, approximately one-third of an observed patient population to had been diagnosed with moderate to severe COVID-19 during the early outbreak in Europe was still experiencing signs of thyroid inflammation after 3 months, despite thyroid function having already normalized. Source: MDMag. To view the third party content, kindly click on the link below or read more. You will then leave this site and enter a third party site.

read more

Omalizumab (Xolair) benefitted sleep disturbance among patients with nasal polyposis over a span of 76 weeks, ... read more
As covered by Lakiea Wright, MD, in a previous interview segment with HCPLive® during the American ... read more
A collection of articles published at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 ... read more
At the American Academy of Allergy, Asthma & Immunology (AAAAI) 2021 Virtual Sessions this weekend, a ... read more